ABVC BioPharma, Inc. (ABVC) stock
ABVCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ECOC
$0.94+0.03 (+3.30%)
Close on Nov 16, 2026Market cap $25.06MP/E –Yield –
ABVC BioPharma operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
ABVC BioPharma's operating cash flow for the twelve months ending Jun 30, 2026 was -$2.69M. For fiscal 2025 it was -$2.99M. The highest annual figure on record is $1.17K in fiscal 2014.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$2.99M | – |
| FY2024 | Dec 31, 2024 | -$1.81M | – |
| FY2023 | Dec 31, 2023 | -$4.19M | – |
| FY2022 | Dec 31, 2022 | -$7.40M | – |
| FY2021 | Dec 31, 2021 | -$7.60M | – |
| FY2020 | Dec 31, 2020 | -$4.56M | – |
| FY2019 | Dec 31, 2019 | -$3.13M | – |
| FY2017 | Sep 30, 2017 | -$1.60M | – |
| FY2016 | Sep 30, 2016 | -$3.47M | -297592.0% |
| FY2014 | Sep 18, 2014 | $1.17K | – |
| FY2013 | Sep 30, 2013 | -$37.77K | – |
| FY2012 | Sep 30, 2012 | -$915.12K | – |
| FY2011 | Sep 30, 2011 | -$1.59M | – |
| FY2010 | Sep 30, 2010 | -$1.05M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | -$244.41K | – |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | -$894.24K | – |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | -$587.58K | – |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | -$964.71K | -1701.7% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | -$894.17K | – |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | -$539.83K | – |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | -$702.13K | – |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | $60.23K | – |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | -$211.43K | – |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | -$955.82K | – |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -$430.46K | – |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | -$1.36M | – |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | -$899.83K | – |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | -$1.50M | – |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | -$461.07K | – |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | -$513.70K | – |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | -$3.43M | – |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | -$2.99M | – |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | -$2.52M | – |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | -$2.22M | – |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | -$1.44M | – |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | -$1.41M | – |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | -$2.19M | – |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | -$328.80K | – |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | -$1.42M | – |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | -$630.94K | – |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | -$1.50M | – |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | -$242.21K | – |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | -$796.97K | – |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | -$599.53K | – |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | -$323.20K | – |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | -$188.36K | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | -$862.24K | -293.6% |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | -$224.89K | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | -$211.37K | – |
| Q3 FY2016CQ2 2016 | Jun 30, 2016 | -$2.83M | – |
| Q2 FY2016CQ1 2016 | Mar 31, 2016 | $445.43K | – |
| Q1 FY2016CQ4 2015 | Dec 31, 2015 | -$874.28K | – |
See a number that looks wrong?